Medication Affordability and Patent Integrity Act

House Bill 5429 - Medication Affordability and Patent Integrity Act: Overview, Status, and Impact

Hozzl · 2024-02-05T14:30:09Z

Explore the details of House Bill 5429 Medication Affordability and Patent Integrity Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Commerce. Stay informed on legislative developments.

2/5/2024, 2:30 PM

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5429

Bill HR 5429 is currently in the status of Bill Introduced since September 13, 2023. Bill HR 5429 was introduced during Congress 118 and was introduced to the House on September 13, 2023. Bill HR 5429's most recent activity was Referred to the Subcommittee on Health. as of September 15, 2023

Bipartisan Support of Bill HR 5429

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5429

Primary Policy Focus

Commerce

Alternate Title(s) of Bill HR 5429

Medication Affordability and Patent Integrity Act

To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.